EUVIMEDEUVIMED entdecken
Leserbrief

GSH-Responsive GalNAc-Conjugated Glycopolymer for Targeted Survivin siRNA Delivery in Hepatocellular Carcinoma Therapy

Mengfei Yin, Lihao Wang, Yang Liu, Jingjing Chen, Hongming Gao, Jinlong Xu, Yuxin Guo, Xinying Cui, Guangli Yu iD, Chao Cai iD

ACS Macro Letters · 20.05.2025 · 14 (5) · 589-596

DOI: 10.1021/acsmacrolett.5c00121 ↗

Kurz gefasst

Leserbrief in der Zeitschrift ACS Macro Letters, online erschienen am 24.04.2025. Verfasst von Mengfei Yin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Key Laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, P. R. Chin…. Hauptthemen laut MEDLINE: RNA, Small Interfering, Survivin, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Department of Science and Technology of Shandong Province, Taishan Scholar Project of Shandong Province, Qingdao National Laboratory for Marine Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene interference therapy has made significant progress in the treatment of various diseases by targeting specific pathogenic genes and down-regulating the production of harmful proteins. This approach enables the precise modulation of gene expression, offering potential therapeutic benefits for conditions driven by genetic mutations or abnormal protein accumulation. Survivin, an apoptosis-inhibiting protein, plays a critical role in regulating tumor cell proliferation and preventing programmed cell death. Its overexpression in liver cancer cells is strongly associated with poor prognosis and accelerated tumor progression. RNA interference (RNAi) therapy can effectively suppress the expression of Survivin in liver cancer, inhibiting tumor cell proliferation and promoting apoptosis. In this study, four distinct GalNAc-conjugated glycopolymer siRNA delivery systems were developed. By leveraging the efficient liver-targeting capability of the GalNAc moiety, Survivin-siRNA was specifically delivered to liver cancer cells through either covalent coupling or electrostatic adsorption. In vitro experiments demonstrated the excellent gene silencing effect of these siRNA complexes, highlighting their potential as a promising therapeutic strategy for liver cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingSurvivinLiver NeoplasmsCarcinoma, HepatocellularAcetylgalactosaminePolymersHumansCell Line, TumorHep G2 CellsCell ProliferationApoptosis

Substanzen

RNA, Small InterferingSurvivinBIRC5 protein, humanAcetylgalactosaminePolymers

Autor:innen und Institutionen

  • Shandong Key Laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, P. R. China.
  • Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, P. R. China.
  • Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China.

ORCID-Profile: Guangli Yu, Chao Cai

Förderung

  • Department of Science and Technology of Shandong Province
  • Taishan Scholar Project of Shandong Province
  • Qingdao National Laboratory for Marine Science and Technology
  • National Natural Science Foundation of China
  • Taishan Scholar Climbing Project

Zitieren

APA

Yin, M., Wang, L., Liu, Y., Chen, J., Gao, H., Xu, J., Guo, Y., Cui, X., Yu, G., & Cai, C. (2025). GSH-Responsive GalNAc-Conjugated Glycopolymer for Targeted Survivin siRNA Delivery in Hepatocellular Carcinoma Therapy. ACS Macro Letters, 14(5), 589-596. https://doi.org/10.1021/acsmacrolett.5c00121

Vancouver

Yin M, Wang L, Liu Y, Chen J, Gao H, Xu J, et al. GSH-Responsive GalNAc-Conjugated Glycopolymer for Targeted Survivin siRNA Delivery in Hepatocellular Carcinoma Therapy. ACS Macro Letters. 2025;14(5):589-596. doi:10.1021/acsmacrolett.5c00121

BibTeX
@article{Yin2025,
  author = {Yin, Mengfei and Wang, Lihao and Liu, Yang and Chen, Jingjing and Gao, Hongming and Xu, Jinlong and Guo, Yuxin and Cui, Xinying and Yu, Guangli and Cai, Chao},
  title = {GSH-Responsive GalNAc-Conjugated Glycopolymer for Targeted Survivin siRNA Delivery in Hepatocellular Carcinoma Therapy},
  journal = {ACS Macro Letters},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {589--596},
  doi = {10.1021/acsmacrolett.5c00121}
}
Kostenlos starten →